XVIPF Stock: Xvivo Perfusion AB (publ) Stock Price, Analysis & Insights
Get live XVIPF stock price $29.39, comprehensive Xvivo Perfusion AB (publ) stock analysis, charts, news, and expert forecast. Real-time XVIPF stock data and investment insights.
Loading chart data...
Xvivo Perfusion AB (publ) (XVIPF) Overview
Xvivo Perfusion AB (publ) (XVIPF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Devices industry . As of the latest trading session, XVIPF trades at $29.39 with a market capitalization of 925.77M . Over the past 52 weeks, XVIPF has traded between $16.98 and $32.90 , with the current price positioned at approximately 78% of this range . The stock curre...
Key Takeaways
- Operates in the Healthcare sector (Medical - Devices)
- Market cap: 925.77M
- Current price: $29.39
- 52-week range: $16.98 - $32.90
- P/E ratio: 117.56
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Xvivo Perfusion AB (publ) is a medical technology company dedicated to advancing transplantation medicine. The firm specializes in pioneering solutions for the preservation and perfusion of organs, tissues, and cells, essential for successful transpl...
Company Information
- CEO
- Christoffer Rosenblad
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 193
Contact Information
- Address
- MAessans gata 10
- Country
- SE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 117.6)
✓ Higher growth potential with elevated volatility (Beta: 1.44)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Xvivo Perfusion AB (publ) shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Xvivo Perfusion AB (publ)
- ⚠Investors should consider how Xvivo Perfusion AB (publ) fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 117.6) requires strong growth to justify
Market Cap
925.77M
P/E Ratio (TTM)
117.56
Beta
1.44
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare XVIPF with peer companies:
- Price
- $22.49
- Market cap
- 662.29M
- Price
- $0.65
- Market cap
- 542.78M
- Price
- $0.80
- Market cap
- 549.63M
- Price
- $13.49
- Market cap
- 321.76M
- Price
- $2.66
- Market cap
- 1.58B
- Price
- $0.00
- Market cap
- 97.18K
- Price
- $0.00
- Market cap
- 16.55K
- Price
- $6.19
- Market cap
- 567.36M
- Price
- $2.78
- Market cap
- 444.36M
- Price
- $0.15
- Market cap
- 316.66M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.